Calcitonin antibody/antigen (BSA/OVA/KLH conjugated hapten)

 Download 

anti-Calcitonin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Go to Hormones diagnostics products collection >>

Product information

Size： 1mg | 10mg | 100mg

Product Description

BSA-Calcitonin

OVA-Calcitonin

Anti-Calcitonin mouse monoclonal antibody

Anti-Calcitonin human monoclonal antibody

Reference

Validation Data

Click to get more Data / Case study about the product.

Biomarker Information

1. Calcitonin: A Comprehensive Exploration of its Role in In Vitro Diagnosis

Calcitonin, a pivotal peptide hormone, commands a central role in the landscape of in vitro diagnosis, particularly in the comprehensive evaluation and management of specific medical conditions.

Role in In Vitro Diagnosis (Serial Number 1): Calcitonin is celebrated as a critical biomarker, revered for its instrumental role in the diagnosis and monitoring of thyroid-related disorders. Its primary domain of application centers on the early detection of medullary thyroid carcinoma (MTC), a rare and potentially aggressive form of thyroid cancer. Elevated levels of calcitonin in serum or plasma are sentinel indicators, triggering further diagnostic assessments and therapeutic interventions. Moreover, calcitonin measurements are indispensable for gauging the efficacy of treatments and meticulously tracking disease progression in MTC patients.

2. The Significance of Precise Calcitonin Measurement

a. Early Detection of Thyroid Cancer (Serial Number 2a): The meticulous quantification of calcitonin stands as an indispensable tool for the early identification of medullary thyroid carcinoma (MTC). MTC, characterized by its aggressive nature, offers the most favorable treatment prospects when detected at an incipient stage. Routine assessment of calcitonin levels empowers healthcare providers to unearth MTC in its nascent phases, facilitating prompt therapeutic interventions and bolstering patient outcomes.

b. Treatment Monitoring (Serial Number 2b): In the context of diagnosed MTC, the monitoring of calcitonin levels assumes pivotal importance in evaluating the efficacy of treatment modalities. Precise calcitonin measurement furnishes healthcare professionals with a nuanced understanding of treatment responses, enabling informed decisions concerning treatment adjustments. This, in turn, optimizes therapeutic outcomes and enhances the quality of life for MTC patients.

c. Risk Assessment (Serial Number 2c): For individuals harboring a family history of MTC or those identified with genetic mutations associated with the disease, measuring calcitonin levels serves as an invaluable risk assessment tool. Elevated calcitonin levels in such individuals act as beacons, prompting heightened vigilance and facilitating proactive measures to mitigate disease progression and reduce associated risks.

d. Fueling Scientific Advancements (Serial Number 2d): Calcitonin measurement catalyzes scientific inquiry and innovation in the sphere of thyroid cancer research. Researchers rely on precise calcitonin data to explore novel diagnostic techniques, innovative therapeutic approaches, and potential interventions. These pioneering endeavors translate into tangible advancements that benefit patients, enhance treatment protocols, and advance the frontiers of medical science.

e. Public Health Impact (Serial Number 2e): Timely calcitonin measurement contributes substantively to public health initiatives aimed at mitigating the impact of thyroid cancer. Early detection and intervention not only elevate survival rates but also alleviate the burden on healthcare systems, optimize resource allocation, and foster comprehensive well-being.

In synopsis, Calcitonin emerges as an indispensable biomarker in in vitro diagnosis, particularly for the early identification and management of medullary thyroid carcinoma (MTC). The precise quantification of calcitonin levels assumes paramount importance in enhancing patient outcomes, monitoring treatment efficacy, assessing risk, propelling scientific progress, and fortifying public health endeavors vis-à-vis thyroid cancer. Our biopharmaceutical enterprise ardently commits itself to furnishing state-of-the-art solutions, including anti-small molecule antibodies and small molecule competitive antigens. These cutting-edge tools empower meticulous and dependable calcitonin measurement across multifarious applications within the medical and research domains, perpetuating our legacy of scientific excellence and healthcare advancement.

About GDU